Cardiovascular Risk Factors Associated with Insulin Resistance: Effects of Oral Antidiabetic Agents

Author： Granberry Mark C.   Fonseca Vivian A.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.3, 2005-01, pp. : 201-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidiabetic Drugs Present and Future: Will Improving Insulin Resistance Benefit Cardiovascular Risk in Type 2 Diabetes Mellitus?

By Campbell I.W.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1017-1028

Adis International

Access to resources Recommend Favorite

Effects of the Thiazolidinediones on Cardiovascular Risk Factors

By Gilling L.   Suwattee P.   DeSouza C.   Asnani S.   Fonseca V.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite

Oral Antidiabetic Agents: A Guide to Selection

By Scheen J.   Lefèbvre P.J.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 225-236

Adis International

Access to resources Recommend Favorite

Is aspirin resistance associated with increased cardiovascular risk?

By  

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects

By Pfützner Andreas   Weber Matthias M   Forst Thomas  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1985-1998

Informa Healthcare

Access to resources Recommend Favorite